Matthew J. Traylor - Concepedia

Author

Matthew J. Traylor

University of Alabama at Birmingham ORCID

Also Known As

M Traylor, M. J. Traylor, M. Traylor, Matthew J Traylor, Matthew J. Traylor, Matthew Traylor

Publications

747

Citations

H-Index

Concepts

All Affiliations

University of Alabama at Birmingham The University of Queensland Takeda (United States)The University of Melbourne

About

Matthew J. Traylor is an author at University of Alabama at Birmingham specializing in medicine, natural sciences, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	645
2	Natural Sciences	5	5	137
3	Biochemistry	2	2	58
4	Engineering	1	1	14
5	Health Sciences	1	1	474

Matthew J. Traylor

Publications

717

Citations

H-Index

Page 1

	Year	Citations
Long-term antibacterial efficacy of air plasma-activated water Matthew J. Traylor, Matthew J. Pavlovich, Sharmin Karim, Journal of Physics D Applied Physics Paw GenerationWater TreatmentToxicologyEnvironmental MicrobiologyInfection Control	2011	474
Hypoxia stimulates endothelial cell angiotensin-converting enzyme antigen synthesis S. J. King, François M. Booyse, Pao‐Hwa Lin, American Journal of Physiology-Cell Physiology HypertensionRedox BiologyOxidative StressInflammationNormoxic Controls	1989	78
Soluble and membrane-bound Drosophila melanogaster CYP6G1 expressed in Escherichia coli: Purification, activity, and binding properties toward multiple pesticides Matthew James Cheesman, Matthew J. Traylor, Margaret E. Hilton, Insect Biochemistry and Molecular Biology BiochemistryNatural SciencesPesticide ResistanceEscherichia ColiMolecular Biology	2013	44
Isolation and interrelationships of the multiple molecular tissue-type and urokinase-type plasminogen activator forms produced by cultured human umbilical vein endothelial cells. François M. Booyse, Julian Scheinbuks, Pao‐Hwa Lin, Journal of Biological Chemistry HistocompatibilityImmunologyAntigen ProcessingCellular PhysiologyAngiogenesis	1988	31
Purification and properties of a single-chain urokinase-type plasminogen activator form produced by subcultured human umbilical vein endothelial cells. François M. Booyse, Pao‐Hwa Lin, Matthew J. Traylor, Journal of Biological Chemistry Fibrinolytic ActivityLow Fibrinolytic ActivityImmunologyPathologyCellular Physiology	1988	28
Comprehensive Discovery and Quantitation of Protein Heterogeneity via LC-MS/MS Peptide Mapping for Clone Selection of a Therapeutic Protein Matthew J. Traylor, Anna Tchoudakova, A. M. Lundquist, Analytical Chemistry Peptide EngineeringGlycobiologyMolecular BiologyComprehensive DiscoveryHost Cell Line	2016	20
Recombinant expression and characterization of Lucilia cuprina CYP6G3: Activity and binding properties toward multiple pesticides Matthew J. Traylor, Jong‐Min Baek, Katelyn E. Richards, Insect Biochemistry and Molecular Biology Lucilia Cuprina Cyp6g3Bioorganic ChemistryBiochemistryNatural SciencesBiotechnology	2017	14
Protein Engineering on Human Recombinant Follistatin: Enhancing Pharmacokinetic Characteristics for Therapeutic Application Chuan Shen, Andrea Iskenderian, Dianna Lundberg, Journal of Pharmacology and Experimental Therapeutics EngineeringHuman GrowthMolecular RegulationImmunologyBiological Therapy	2018	14
VEGFR-1/Flt-1 inhibition increases angiogenesis and improves muscle function in a mouse model of Duchenne muscular dystrophy Jennifer Bosco, Zhiwei Zhou, Sofie Gabriëls, Molecular Therapy — Methods & Clinical Development	2021	14

Page 1